Quantcast

Latest Lipoproteins Stories

2014-07-23 08:32:18

In addition, preliminary results from an Australian sponsored trial have yet to verify whether the mechanism of RVX-208 action may affect glucose metabolism. TSX Exchange Symbol: RVX CALGARY, July 23, 2014 /PRNewswire/ - Resverlogix Corp. (TSX: RVX) announced today findings from the recent analysis of Major Adverse Cardiovascular Events (MACE) data in patients with diabetes mellitus (DM) enrolled in both the ASSURE and SUSTAIN trials. In ASSURE, MACE was a pre-specified...

2014-07-17 08:28:35

CARLSBAD, Calif., July 17, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the initiation of a Phase 2 study evaluating ISIS-APO(a)(Rx) in patients with high lipoprotein(a), or Lp(a), an independent risk factor for cardiovascular disease. Patients with high levels of Lp(a) have an increased risk of atherosclerosis, coronary heart disease, aortic stenosis, heart attack and stroke. ISIS-APO(a)(Rx) is designed to reduce Lp(a) by inhibiting the production of...

2014-07-09 08:29:03

INDIANAPOLIS, July 9, 2014 /PRNewswire/ -- Chek Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products, announced today that it has signed a marketing, sales, and distribution agreement with Independent Medical Co-Op, Inc. (IMCO), one of the premier associations for independent medical distributors. IMCO is a cooperative association of over 140 medical supply distributors that serve the physician, hospital,...

2014-06-27 23:05:56

As hormone levels change during the transition to menopause, the quality of a woman’s cholesterol carriers degrades, leaving her at greater risk for heart disease, researchers at the University of Pittsburgh Graduate School of Public Health discovered. Pittsburgh, Pennsylvania (PRWEB) June 27, 2014 As hormone levels change during the transition to menopause, the quality of a woman’s cholesterol carriers degrades, leaving her at greater risk for heart disease, researchers at the...

2014-06-25 08:30:43

The lives of millions of Americans are potentially at risk. NEW YORK, June 25, 2014 /PRNewswire-USNewswire/ -- The EPA Drug Initiative (EPADI) urges the FDA to thoughtfully consider new and almost irrefutable proof that high triglycerides are a significant risk factor contributing to cardiovascular disease-related death and morbidity. http://photos.prnewswire.com/prnvar/20140625/121320 This past week, two independent studies were published in the prestigious New England Journal of...

2014-06-24 08:30:56

Achievement of LDL Particle Targets Associated with More Aggressive Lipid-lowering Therapy and Better Clinical Outcomes Compared to Patients Managed to LDL Cholesterol Targets RALEIGH, N.C., June 24, 2014 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), today announced the publication of the first large-scale real world study evidencing a link between low LDL-P and reduced cardiovascular disease (CVD) risk. Data in the study published in Atherosclerosis demonstrated that high-risk...

2014-06-18 20:21:54

Loss-of-function mutations in APOC3 gene lower blood lipids and lower risk of coronary artery disease CAMBRIDGE, Mass., June 18, 2014 /PRNewswire/ -- By scouring the DNA of thousands of patients, researchers at the Broad Institute, Massachusetts General Hospital, and their colleagues have discovered four rare gene mutations that not only lower the levels of triglycerides, a type of fat in the blood, but also significantly reduce a person's risk of coronary heart disease -- dropping...

2014-06-16 12:45:00

Intermountain Medical Center For prediabetics, many interventions focus on lifestyle changes and weight loss, but new research on periodic fasting has identified a biological process in the body that converts bad cholesterol in fat cells to energy, thus combating diabetes risk factors. Researchers at the Intermountain Heart Institute at Intermountain Medical Center in Murray, Utah, noticed that after 10 to 12 hours of time fasting, the body starts scavenging for other sources of energy...

2014-06-16 09:46:15

American Diabetes Association Panelists will argue pros and cons at symposium New guidelines for the treatment of high cholesterol are not appropriate for people with type 2 diabetes – or are they? Two researchers will debate the topic at a symposium to be held on Tuesday, June 17, at the American Diabetes Association's 74th Scientific Sessions®. At issue are the newest guidelines issued jointly by the American College of Cardiology and American Heart Association in November...

2014-06-10 08:32:00

INDIANAPOLIS, June 10, 2014 /PRNewswire/ -- Chek Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products, announced today that they have signed an agreement to provide their CardioChek Plus analyzers and lipid panel test strips to eHealthScreenings, a leading provider of onsite comprehensive wellness screening services. Clients of eHealthScreenings include third-party administrators, employee assistance...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related